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1. Introduction 
The synapse is the focal point for neuronal communication and neuron-glia interactions. 
Synaptic structure and function are intimately related and many of the proteins that provide 
structure to the synapse also regulate synaptic function (Abe et al. 2004, Couchman 2003, 
Ehlers 2002, Passafaro et al. 2003). The synaptic structure - function relationship is highly 
apparent during pathological conditions. This is exemplified in neurodegenerative 
disorders, such as Alzheimer’s disease, where synaptic function is positively correlated with 
neuronal function (Gasic & Nicotera 2003) and viability (Deisseroth et al. 2003), with 
synaptic pathology preceding cell death (Gasic & Nicotera 2003). 
Maintenance of synaptic structure and functionality is a process that is highly energy 
dependent. Studies of synaptosomal morphology and metabolism have indicated that the 
synapse is highly susceptible to ischemic damage (Pastuszko et al. 1982, Rafalowska et al. 
1980, Sulkowski et al. 2002, Enright et al. 2007, Zhang & Murphy 2007). This exceptional 
requirement for energy necessitates the localization of numerous mitochondria proximal to 
the synaptic bouton and mitochondria are a commonly observed feature in synaptosomal 
preparations (Costain et al. 2008). Synaptosomal metabolic activity (Rafalowska et al. 1980) 
and the rate of neurotransmitter re-uptake (Pastuszko et al. 1982) are decreased following 
acute hypoxia. Furthermore, Sulkowski et al (2002) observed that ischemia decreases 
synaptosomal oxygen consumption and metabolic capacity for a period of 24 hours. 
Cerebral ischemia induces a marked depletion in synaptic vesicle content and increases the 
number of damaged mitochondria (Sulkowski et al. 2002, Costain et al. 2008). Importantly, 
ischemia-induced alterations in synaptosomal morphology are indistinguishable from that 
of brain slices (Sulkowski et al. 2002). Ischemia-like conditions (hypoxic stress or 
excitotoxicity) induce dramatic and rapidly reversible structural/morphological changes in 
dendritic spines (Hasbani et al. 2001, Mattson et al. 1998, Park et al. 1996, Enright et al. 2007, 
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Zhang & Murphy 2007). The structural (Park et al. 1996) and biochemical alterations 
(Martone et al. 1999) at the synapse rapidly return to normal following cessation of ischemic 
stressors. This initial period of apparent recovery is followed by a period of morphological 
and biochemical alterations that persist for upwards of 24 hours (Martone et al. 1999). 
Similarly, dysregulation of synaptic adhesion is observed prior to the onset of neuronal cell 
death and continues thereafter (Costain et al. 2008). These studies indicate that the synapse 
is highly responsive to ischemia and is an important modulator of post-ischemic neuronal 
fate. Signals triggered at the synapse propagate toward the cell body and instigate delayed 
post-ischemic neuronal death in a process termed as synaptic apoptosis (Mattson et al. 
1998). 
Synaptically localized signals, either anti- or pro-apoptotic, can be propagated to the cell 
body in both an anterograde and retrograde manner (Mattson & Duan 1999). Apoptotic 
stimuli have been shown to induce caspase-3 activation, mitochondrial membrane 
depolarization and phospholipid asymmetry in isolated synaptosomes (Mattson et al. 
1998). Similarly, trophic factor withdrawal increases axonal caspase-3 activity, but not 
within the neuronal soma (Mattson & Duan 1999). In hippocampal neurons, apoptotic 
signals initiated at the dendrites have been shown to subsequently spread toward the cell 
body (Mattson & Duan 1999). Synaptic apoptosis may be a mechanism that is necessary 
for synaptic remodeling under non-pathological conditions as well as contributing to or 
initiating neuronal apoptosis during pathological conditions. Pro-apoptotic proteins have 
been found to play a role in non-pathological processes such as neurogenesis, neurite 
outgrowth and synaptic plasticity (Mattson & Gleichmann 2005). This suggests that 
signals triggered at the synapse may propagate toward the cell body and instigate post-
ischemic neuronal death. 
Cellular protein levels are determined by the balance between the rates of synthesis and 
degradation, and cerebral ischemia has a pronounced effect on these processes. The 
transcriptional response to cerebral ischemia has been studied using high throughput 
methods under a variety of experimental conditions (Gilbert et al. 2003, MacManus et al. 
2004). Similarly, cerebral ischemia-induced protein degradation has been examined for a 
variety of individual proteins. Activation of a variety of proteases, such as members of the 
caspase, calpain and cathepsin families, is a well-described consequence of cerebral ischemia 
(Vanderklish & Bahr 2000, Kagedal et al. 2001). Complicating this is the observation that 
cerebral ischemia causes proteosomal (DeGracia et al. 2002), lysosomal (Costain et al. 2010), 
mitochondrial (Costain et al. 2010) and endoplasmic reticulum dysfunction (Ge et al. 2007). 
Thus, it is almost impossible to predict post-ischemic cellular protein levels from gene 
expression data alone. When focusing on a subcellular structure, such as the synapse, an 
additional mechanism will impact protein levels. Intracellular transport mechanisms can 
target a protein to a specific region or be involved in sequestering proteins away from their 
original location (Zhao et al. 2005, Vanderklish & Bahr 2000). As a result of these factors, the 
best approach for determining post-ischemic synaptic protein levels is to perform a direct 
assessment using proteomic methodologies. 
An understanding of the cell death processes that are precipitated by exposure to cerebral 
ischemia is necessary for designing rational therapeutic intervention. Considering that cell 
death can be mediated by multiple inter-related mechanisms, it is perhaps unsurprising that 
the majority of single target small molecules have failed in clinical trials for stroke (Ginsberg 
2008). The role of apoptotic cell death in cerebral ischemia has long been studied (Hou & 
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MacManus 2002), and more recently ischemia induced autophagy has become an active area 
of interest (Liu et al. 2010). While necrotic cell death is well known to occur in cerebral 
infarcts, the recent identification of programed necrosis, or ‘necroptosis’, has reinvigorated 
research in ischemia-induced necrotic cell death. 
 
 
Fig. 1. Outline of the ischemic synaptosomal proteomic analysis procedure. Focal ischemia 
was performed 20 hours prior to the isolation of the ipsilateral (ischemic) and contralateral 
(non-ischemic) mouse brain hemispheres. Synaptosomes were isolated from the entire 
forebrain hemispheres and processed as described in the diagram. 
While cell death mechanisms are typically viewed as pathways involving multiple proteins 
and organelles, neuronal pathology can also be examined from an organelle centric 
perspective. Organelle dysfunction can precipitate the initiation of cell death pathways, 
rather than simply being relay points for signaling events. The essence of this distinction is 
the difference between extrinsic activation of cell death and internal/intrinsic activation. 
The primary route of activation of cell death following cerebral ischemia is through intrinsic 
pathways involving the mitochondria, lysosomes endoplasmic reticulum, and nucleus 
(Yamashima & Oikawa 2009, Chen et al. 2010, Ankarcrona et al. 1995). Thus, a strategy that 
involves examining the interaction between organelles during pathological conditions may 
enable the identification of new targets that can be exploited as therapies for cerebral 
ischemia. 
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The effects of cerebral ischemia are often, by necessity, described from a highly reductionist 
point of view, with most studies focusing on specific signaling pathways or individual 
molecules. Conversely, genomic and proteomic datasets offer the opportunity to expand the 
scope of understanding and enable the interpretation of systematic responses. While there is 
a wealth of data available describing neuronal proteins localized in synaptosomes as well as 
pre-synaptic and post-synaptic preparations, to date studies on the effects of cerebral 
ischemia on the synaptic proteome are limited (Costain et al. 2008). The aim of this chapter 
is to integrate new and existing genomic and proteomic datasets to provide a 
comprehensive understanding of the effect of cerebral ischemia on the function of neuronal 
organelles, as well as their role in mediating cell death and / or neuroprotection. 
2. Materials and methods 
2.1 Animal care 
A local committee for the Canadian Council on Animal Care approved all procedures using 
mice. The C57B mice were purchased from Charles River Canada (St-Constant, PQ). Under 
temporary isoflurane anesthesia, the mice (20-23 g) were subjected to occlusion of the left 
middle cerebral artery (MCAO) using an intraluminal filament as previously described 
(Costain et al. 2008). After 1 hr of ischemia, the animals were briefly reanesthetized, the 
filament withdrawn and wounds sutured. After 20 hrs of reperfusion, mice were briefly 
anesthetized with isoflurane and the brain rapidly excised and dissected on ice. 
2.2 Synaptosome preparation 
Contralateral (CT) and ischemic (IS) hemispheres from one mouse were manually 
homogenized in 2 ml of HM buffer (0.32 M sucrose, 1 mM EDTA, 0.25 mM DTT, 1 U/ml 
RNasin (Promega)) using a dounce homogenizer, 800 rpm 13 strokes at 4 °C. The 
homogenates were centrifuged (1000 g for 10 min at 4 C) and the supernatant retained. The 
pellet was homogenized and centrifuged (as before) a second time. The first and second 
supernatants were transferred to 2 ml polycarbonate tubes and centrifuged at 20,000 g for 20 
min at 4 C. The resultant pellet was resuspended in 2 ml HM buffer using a dounce 
homogenizer. Discontinuous sucrose:percoll gradients were prepared by layering 2 ml each, 
in order, of 25% (percoll in HM buffer), 15%, 10% and 3% into 10 ml polycarbonate 
centrifuge tubes. One ml of the sample was then layered on top of a gradient and 
centrifuged at 32,000 g for 5 min at 4 C. Five fractions were collected following 
centrifugation: F1 - 3% percoll (cytoplasm), F2 - interface between 3% and 10% percoll 
(myelin), F3 - interface between 10% and 15% percoll (small synaptosomes, myelin & 
mitochondria), F4 - interphase between 15% and 25% percoll (intact synaptosomes), and F5 - 
pellet (mitochondria). Fractions F1 - F4 were made up to 3 ml with HM buffer and 
centrifuged at 12,000 g for 20 min at 4 C. The supernatant was removed and the pellet 
washed with 1 x PBS, twice (each time spinning at 12000 x g for 10min). The final pellet was 
resuspended in either HM buffer or 50 mM Tris pH 8.5, 0.1% SDS. The physical and 
biochemical characteristics of the synaptosome preparation used here are described in 
further detail in Costain et al. (2008). 
2.3 Protein preparation, digestion and ion exchange chromatography 
Proteins from each synaptosome sample were precipitated by adding 10 volumes of cold 
acetone and incubating at 1 h at -20 C followed by centrifugation at 5000g for 5 min. Pellets  
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Fig. 2. NanoLC-MS analysis of contralateral (control) and ipsilateral (stroke) samples. Shown 
are images representing the nanoLC-MS data from each sample, where each spot represents 
a peptide ion. MatchRx software was used to extract peptide data, align the control and 
stroke datasets and correct retention time variations. Shown are the merged images before 
and after MatchRx-dependent correction. More than 5000 ions were detected per sample. 
were dissolved in an appropriate volume of denaturing buffer (50 mM Tris-HCl, pH 8.5, 
0.1% SDS) to a final protein concentration of 2 mg/mL. One hundred µg of each protein was 
transferred to a fresh tube. The proteins were reduced using dithiothrietol (4 mM, 10 min at 
95 C), alkylated using iodoacetamide (10 mM, 20 min at room temperature in dark), and 
digested using 5 µg of MS-grade trypsin gold (Promega, 12-18 h at 37 C). The digested 
peptides were diluted 10-fold in 10 mM KH2PO4, pH 3.0, 25% acetonitrile and loaded onto a 
cation exchange column (POROS® 50 HS, 50-µm particle size, 4.0 mm x 15 mm, Applied 
Biosystems) for separation. Five fractions were eluted using step-gradient of 0-350 mM KCl. 
Each fraction was evaporated to dryness and dissolved in 5% acetronitrile, 1% acetic acid for 
analysis by mass spectrometry (MS). 
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Fig. 3. Scatter plot showing relative expression of peptides in stroke and control 
synaptosomes. Peptide intensities were extracted from nanoLC-MS runs using MatchRx and 
ratio-intensity plots of stroke-vs-control samples after global median normalization were 
plotted. Peptides showing up (red) or down (green) regulation by 1.5-fold in stroke relative 
to control samples and showing a p <0.05 were considered differentially expressed. These 
corresponded to ~27% of the peptides and were used for targeted identification using 
nanoLC-MS/MS. 
2.4 MS analysis and protein identification 
A hybrid quadrupole time-of-flight MS (Q-TOF Ultima, Waters, Millford, MA) with an 
electrospray ionization source (ESI) and with an online reverse-phase nanoflow liquid 
chromatography column (nanoLC, 0.075 mm × 150 mm PepMap C18 capillary column, 
Dionex/LC-Packings, San Francisco, CA) was used for all analyses. Samples were separated 
on the nanoLC column using a gradient of 5-75% acetonitrile and 0.2% formic acid in 90 
min, at 350 nL/min supplied by a CapLC HPLC pump (Waters). Five percent of each 
sample was first analyzed by nanoLC-MS in a survey (MS-only) mode for quantitation using 
MatchRx software as described recently (Haqqani et al. 2008). Briefly, each scan was 
background-subtracted, Savitzky-Golay-based smoothed, and centroided using Masslynx 
software v4.0 (Waters) and exported as an mzXML file (Pedrioli et al. 2004). Using MatchRx 
software, isotopic distribution pattern, charge state, and quantitative abundance of peptides 
in each nanoLC-MS run were determined. The peptides were then aligned across multiple 
nanoLC-MS runs through a neighboring-peak finding algorithm (Haqqani et al. 2008) 
followed by quantitatively comparing the levels of each peptide in the ipsilateral and 
contralateral fractions to identify differentially expressed peptides. Peptides showing 
consistent log2 fold-change of >1.5 or <-1.5 among biological replicates and showing 
significant difference from mean expression levels (p < 0.05, Wilcoxon matched pairs test) 
were considered differentially expressed. Images of each run were also generated to visually 
validate the differentially expressed peptides using MatchRx (Fig. 4). To sequence the 
differentially expressed peptides, they were included in a 'include list'. Another 5% of each 
sample was then re-injected into the mass spectrometer, and only the peptides included in 
the 'include list' were sequenced in MS/MS mode (targeted nanoLC-MS/MS). All MS/MS 
spectra were obtained on 2+, 3+, and 4+ ions. Peak lists were submitted to a probability-
based search engine, Mascot version 2.2.0 (Matrix Science Ltd., London, U.K.) (Hirosawa et 
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al. 1993). The initial database utilized was a composite of forward and reverse Uniprot-
Swiss-Prot Mus musculus protein database (Aug 2011 containing 16,390 sequences). 
Unmatched peptides were subsequently searched against the remaining Uniprot-Swiss-Prot 
database (Aug 2011 containing 531,473 sequences). Searches were performed with a 
specified trypsin enzymatic cleavage with one possible missed cleavage. The false-positive 
rates (FPR) in database searching by Mascot were calculated as described earlier (Peng et al. 
2003): FPR = (2 × Nrev)/(Nrev + Nfwd), where Nrev is the number of peptides identified 
(after filtering) from the reverse-database, and Nfwd is the number of peptides identified 
(after filtering) from the forward database. To maximize the number of peptides and keep 
the FPR < 0.5%, ion scores > 20, parent ion tolerance of < 0.1 Da, fragment ion tolerance of < 
0.2 Da, and minimal number of missed cleavages were chosen. As an independent statistical 
measure of peptide identification, Peptide Prophet probabilities were also measured. All 
identified peptides had p ≥ 0.90. The MS/MS spectrum of each differentially expressed 
peptide pair was manually examined and confirmed. 
 
 
Fig. 4. Examples of differentially expressed proteins on nanoLC-MS images. Shown are 
merged images representing nanoLC-MS data of control (green image) and stroke (red 
image) samples. The two down-regulated peptides (green) are from 3-Oxoacid CoA 
Transferase 1 (Q9D0K2, Oxct1) and the four up-regulated peptides (red) are from glial high 
affinity glutamate transporter (P43006, Slc1a2). Peptides were identified by targeted 
nanoLC-MS/MS. In each image, inset shows a close-up image of the indicated peptide and 
the fold-change in stroke sample relative to control. For detailed list see Tables 1 and 2. 
3. Results 
3.1 Label-free proteomic analysis of ischemic synaptosomes 
An outline of the experimental procedure is provided in Fig. 1. Following cerebral ischemia, 
the ipsilateral and contralateral hemispheres were separated and synaptosomal proteins 
isolated. The proteins from each sample were digested into sequenceable peptides, 
separated into 4 cation exchange chromatography fractions and analyzed by nanoLC-MS to 
quantify the level of each peptide. Each cation exchange fraction contained more than 12,000 
peptide peaks as identified by nanoLC-MS analysis (Fig. 2). MatchRx software was thus 
used to identify quantitative differences in the nanoLC-MS runs between all the ipsilateral 
and contralateral fractions. The software extracts peptide-peak intensities and enables 
correction of retention time variations amongst multiple nanoLC-MS runs (Fig. 2), thus 
allowing accurate peptide alignment and quantitative comparison of the samples. Statistical 
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analyses were carried out to identify differentially expressed peaks, resulting in the 
determination that 27% of the peaks showed differential expression (≥ 1.5 fold difference) 
between the two hemispheres (Fig. 3). As the variability between two biological 
synaptosomal preps was found to be about 10% (unpublished data), the observed 
differences were primarily attributable to the effects of cerebral ischemia and much less due 
to biological variability. 
 
 
Fig. 5. Linear regression analysis of bias in label-free proteomics data. Expression data were 
plotted against protein mass and mascot score in panels A and B, respectively. Error values 
were plotted against mascot score in panel C. Linear regression analyses were performed on 
the up (red)- and down (green)-regulated proteins independently. Regression lines are 
plotted in panels B and C. Analyses of the regression slopes did not detect significant 
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departures from zero, indicating that there was no correlation between expression and 
protein size / mascot score or error and mascot score. A runs test indicated that there was 
no departure from linearity in the regression analysis of error versus mascot score. 
Furthermore, no significant differences were detected between the up and down regulated 
proteins in any of the analyses. 
The differentially expressed peaks were then sequenced by re-injecting each fraction and 
analyzing with targeted nanoLC-MS/MS using an include list containing the masses and 
retention times of each targeted peak. The sequenced peptides were used to generate a list of 
ischemia-responsive proteins. A total of 371 proteins were identified as responsive to 
cerebral ischemia (hereafter referred to as either the IS dataset or IS proteins) (Tables 1 and 
2). Two-thirds (68%) of these proteins were up-regulated and the remaining were down-
regulated. Examples of up- and down-regulated proteins are shown in Fig. 4. A series of 
linear regression analyses were performed to ensure that the expression data was free of 
systematic bias. The results of the linear regression analyses indicate that the expression 
values were not correlated to protein mass (Fig. 5A) or Mascot score (Fig. 5B). Similarly, the 
measurement error was not correlated to Mascot score (Fig. 5C). These results indicate that 
the observed expression and error values are due to biological effects. 
 
 
Fig. 6. (A) Venn diagram showing the number of differentially expressed proteins identified 
by label-free proteomics, ICAT proteomics (Costain et al. 2010) and both methods. (B) Venn 
diagram showing the overlap between the IS dataset using label-free proteomics (this study, 
371 proteins) and the known synaptosomal proteins (1582 proteins) in the literature (Cheng 
et al. 2006, Morciano et al. 2005, Phillips et al. 2005, Schrimpf et al. 2005, Witzmann et al. 
2005, Jordan et al. 2004, Peng et al. 2004, Stevens et al. 2003, Li et al. 2004). 
To validate the purity of our synaptosomal preps, the IS proteins were searched against a 
known collection of synaptic protein datasets from recent literature that had been identified 
by proteomics. More than 80% of the IS proteins were found in these datasets (Fig. 6B), 
demonstrating that our preps are consistent with other synaptosomal datasets. However, 
the IS proteins corresponded to only about 23% of all the known synaptic proteins (Fig. 6B), 
which is also consistent with the fact that < 30% of the peaks were found as differentially 
expressed (Fig. 3). Literature mining through PubMed search identified that 56 proteins are 
known to be associated with middle cerebral artery occlusion model of ischemia (Tables 1 
and 2). 
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Accession Symbol Exprs Mito synDB MCAO 
Q9CR67 Tmem33 3.3 ± 0.5  Yes  
Q06185 Atp5i 3.3 ± 0.7 Yes Yes  
O54774 Ap3d1 3.3 ± 0.4  Yes  
P41216 Acsl1 2.8 ± 0.8 Yes Yes  
XP_618960  2.7 ± 0.3 Yes Yes  
Q5NCP0 Rnf43 2.6 ± 0.9 Yes Yes  
O08709 Prdx6 2.6 ± 0.6 Yes Yes 2 
Q8BWF0 Aldh5a1 2.5 ± 0.2 Yes Yes  
Q64487 Ptprd 2.5 ± 0.6  Yes  
Q68FF7 Slain1 2.5 ± 0.5  Yes  
Q8K2B3 Sdha 2.4 ± 0.4 Yes Yes  
P16858 Gapdh 2.4 ± 0.6 Yes Yes 5 
P20108 Prdx3 2.4 ± 0.5 Yes Yes  
P11531 Dmd 2.4 ± 0.5    
Q9QYB8 Add2 2.3 ± 0.4  Yes  
P15105 Glul 2.3 ± 0.5 Yes Yes 8 
Q9QYA2 Tomm40 2.3 ± 0.6 Yes Yes  
Q8VE33 Gdap1l1 2.3 ± 0.3 Yes Yes  
P11881 Itpr1 2.3 ± 0.4  Yes  
Q61207 Psap 2.3 ± 0.5 Yes Yes 3 
Q921L8 Galnt11 2.2 ± 0.4    
P10637 Mapt 2.2 ± 0.7  Yes 4 
Q9CR61 Ndufb7 2.2 ± 0.1 Yes Yes  
Q8BH59 Slc25a12 2.1 ± 0.8 Yes Yes  
Q7TPR4 Actn1 2.1 ± 0.5 Yes Yes  
P97493 Txn2 2.1 ± 0.4 Yes  9 
Q9Z1G4 Atp6v0a1 2.1 ± 0.8  Yes  
P42228 Stat4 2.1 ± 0.1    
NP_001074599 Ogdhl 2.1 ± 0.5 Yes Yes  
Q8BMS1 Hadha 2.1 ± 0.7 Yes Yes  
Q9JLZ3 Auh 2 ± 0.4 Yes Yes  
P81066 Irx2 2 ± 0.6    
Q3TRM8 Hk3 2 ± 0.4  Yes  
P09671 Sod2 2 ± 0.6 Yes Yes 3 
Q60931 Vdac3 2 ± 0.8 Yes Yes  
Q8BMF4 Dlat 2 ± 0.6 Yes Yes  
Q9Z2W1 Stk25 2 ± 0.5   1 
P48318 Gad1 2 ± 0.6 Yes Yes 5 
P06745 Gpi 2 ± 0.2  Yes 1 
O55143 Atp2a2 2 ± 0.7 Yes Yes  
O08599 Stxbp1 2 ± 0.4 Yes Yes  
Q9DCX2 Atp5h 2 ± 0.5 Yes Yes  
P35486 Pdha1 2 ± 0.7 Yes Yes  
P13595 Ncam1 2 ± 0.8  Yes 6 
Q8R4N0 Clybl 2 ± 0.2 Yes  2 
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P35803 Gpm6b 2 ± 0.8  Yes  
Q09666 Ahnak 2 ± 0.5    
Q61792 Lasp1 2 ± 0.8  Yes  
P20152 Vim 1.9 ± 0.4 Yes Yes 9 
Q99P72 Rtn4 1.9 ± 0.5  Yes  
P62874 Gnb1 1.9 ± 0.5 Yes Yes  
Q08460 Kcnma1 1.9 ± 0.5  Yes 5 
Q9CPP6 Ndufa5 1.9 ± 0.3 Yes Yes  
Q8BIZ0 Pcdh20 1.9 ± 0.2    
Q9CR62 Slc25a11 1.9 ± 0.3 Yes Yes  
Q8BVE3 Atp6v1h 1.9 ± 0.4 Yes Yes  
P14094 Atp1b1 1.9 ± 0.9  Yes  
NP_444473 PRSS1 1.9 ± 0.7    
P18872 Gnao1 1.9 ± 0.8  Yes  
P60879 Snap25 1.9 ± 0.5  Yes 8 
Q8VEA4 Chchd4 1.9 ± 0.5 Yes   
P57776-1 Eef1d 1.9 ± 0.4    
P14873 Map1b 1.8 ± 0.8  Yes 4 
Q01279 Egfr 1.8 ± 0.6   5 
Q9ERS2 Ndufa13 1.8 ± 0.5 Yes   
Q8VDD5 Myh9 1.8 ± 0.4  Yes  
Q80Z24 Negr1 1.8 ± 0.5  Yes  
Q925N0 Sfxn5 1.8 ± 0.3 Yes Yes  
Q9UPR5 SLC8A2 1.8 ± 0.5 Yes Yes  
Q8BFR5 Tufm 1.8 ± 0.4 Yes Yes  
Q68FD5 Cltc 1.8 ± 0.7 Yes Yes  
P17426 Ap2a1 1.8 ± 0.4  Yes  
P12960 Cntn1 1.8 ± 0.5  Yes  
Q9CR68 Uqcrfs1 1.8 ± 0.3 Yes Yes  
Q91VD9 Ndufs1 1.8 ± 0.3 Yes Yes  
Q62425 Ndufa4 1.8 ± 0.2 Yes Yes  
Q8CAA7 Pgm2l1 1.8 ± 0.5  Yes  
P50516 Atp6v1a 1.8 ± 0.3 Yes Yes  
Q9Z2I0 Letm1 1.8 ± 0.2 Yes Yes  
Q96PV0 Syngap1 1.7 ± 0.5  Yes  
Q80TJ1 Cadps 1.7 ± 0.5  Yes  
P17742 Ppia 1.7 ± 0.3 Yes Yes 1 
P14231 Atp1b2 1.7 ± 0.6  Yes  
E9Q6J4 Ceacam3 1.7 ± 0.4    
Q9D6M3 Slc25a22 1.7 ± 0.4 Yes Yes  
O55131 Sept7 1.7 ± 0.7  Yes  
P62761 Vsnl1 1.7 ± 0.6  Yes  
Q9D051 Pdhb 1.7 ± 0.3 Yes Yes  
P14824 Anxa6 1.6 ± 0.3 Yes Yes  
Q9QY06 Myo9b 1.7 ± 0.3    
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Accession Symbol Exprs Mito synDB MCAO 
Q61644 Pacsin1 1.7 ± 0.3  Yes  
Q9D2G2 Dlst 1.7 ± 0.3 Yes Yes  
Q9DBL1 Acadsb 1.7 ± 0.4 Yes Yes  
P17182 Eno1 1.7 ± 0.5  Yes  
P63038 Hspd1 1.7 ± 0.7 Yes Yes 10 
Q9ULD0 OGDHL 1.7 ± 0.3 Yes Yes  
Q8BKZ9 Pdhx 1.6 ± 0.3 Yes Yes  
P62748 Hpcal1 1.6 ± 0.2  Yes  
P14211 Calr 1.6 ± 0.4  Yes  
P62482 Kcnab2 1.6 ± 0.5    
P40142 Tkt 1.6 ± 0.3  Yes  
P99029 Prdx5 1.6 ± 0.5 Yes Yes 2 
Q8VEM8 Slc25a3 1.6 ± 0.4 Yes Yes  
P23818 Gria1 1.6 ± 0.4  Yes 5 
O35526 Stx1a 1.6 ± 0.5  Yes  
P51830 Adcy9 1.6 ± 0.4  Yes  
XP_927453  1.6 ± 0.2    
P53994 Rab2a 1.6 ± 0.4 Yes Yes  
P60710 Actb 1.6 ± 0.4 Yes Yes 12 
P31650 Slc6a11 1.6 ± 0.7  Yes 1 
Q9Z2Q6 Sept5 1.6 ± 0.7 Yes Yes  
Q99KI0 Aco2 1.6 ± 0.5 Yes Yes 5 
P46460 Nsf 1.6 ± 0.5  Yes  
Q6IFX4 Krt39 1.6 ± 0.5 Yes   
Q8R404 Qil1 1.6 ± 0.1 Yes Yes  
O09111 Ndufb11 1.5 ± 0.7 Yes Yes  
Q9DC69 Ndufa9 1.5 ± 0.3 Yes Yes  
O88741 Gdap1 1.5 ± 0.5  Yes  
P07477 PRSS1 1.5 ± 0.4  Yes  
P17751 Tpi1 1.5 ± 0.3 Yes Yes  
Q91V61 Sfxn3 1.5 ± 0.3 Yes Yes  
P57780 Actn4 1.5 ± 0.5 Yes Yes  
P97300 Nptn 1.5 ± 0.4  Yes  
Q99LC3 Ndufa10 1.5 ± 0.1 Yes Yes  
P63017 Hspa8 1.5 ± 0.5 Yes Yes  
Q99104 Myo5a 1.5 ± 0.5  Yes 1 
Q9CQ69 Uqcrq 1.5 ± 0.4 Yes Yes  
P46096 Syt1 1.5 ± 0.4  Yes  
Q8CAQ8 Immt 1.5 ± 0.3 Yes Yes  
Q91WF3 Adcy4 1.5 ± 0.3    
Q64133 Maoa 1.5 ± 0.3 Yes Yes 3 
P97807 Fh 1.5 ± 0.2 Yes Yes 1 
Q9Z2I9 Sucla2 1.5 ± 0.2 Yes Yes  
Q63810 Ppp3r1 1.5 ± 0.3    
O94925 GLS 1.5 ± 0.7 Yes Yes  
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Accession Symbol Exprs Mito synDB MCAO 
Q9R1T4 Sept6 1.5 ± 0.3  Yes  
P61922 Abat 1.5 ± 0.3 Yes Yes  
Q61206 Pafah1b2 1.5 ± 0.4    
P06151 Ldha 1.5 ± 0.2 Yes Yes  
P54227 Stmn1 1.5 ± 0.3  Yes 3 
P31648 Slc6a1 1.4 ± 0.5  Yes 1 
P28652 Camk2b 1.4 ± 0.3  Yes  
Q61548 Snap91 1.4 ± 0.2 Yes Yes  
P48962 Slc25a4 1.4 ± 0.2 Yes Yes  
P68254 Ywhaq 1.4 ± 0.2 Yes Yes  
P50518 Atp6v1e1 1.4 ± 0.1 Yes Yes  
Q8VHW2 Cacng8 1.4 ± 0.4  Yes  
O55125 Nipsnap1 1.4 ± 0.3 Yes Yes  
O70566 Diaph2 1.4 ± 0.2 Yes Yes  
P20936 RASA1 1.4 ± 0.2    
Q9ES97 Rtn3 1.4 ± 0.3  Yes  
P50114 S100b 1.4 ± 0.2  Yes 7 
O08553 Dpysl2 1.4 ± 0.4 Yes Yes 2 
Q60930 Vdac2 1.4 ± 0.5 Yes Yes  
Q02053 Uba1 1.4 ± 0.2  Yes  
Q9R0P9 Uchl1 1.4 ± 0.2  Yes 2 
P10126 Eef1a1 1.4 ± 0.6 Yes Yes  
Q60932 Vdac1 1.4 ± 0.3 Yes Yes  
P06837 Gap43 1.4 ± 0.3  Yes 14 
P62835 Rap1a 1.4 ± 0.2 Yes Yes  
Q9D0F9 Pgm1 1.3 ± 0.2  Yes  
P62204 Calm1 1.3 ± 0.2  Yes 25 
P47753 Capza1 1.3 ± 0.4  Yes  
P52480 Pkm2 1.3 ± 0.4 Yes Yes  
Q9QZD8 Slc25a10 1.3 ± 0.4 Yes Yes  
Q9EQF6 Dpysl5 1.3 ± 0.5 Yes  1 
Q5SUA5 Myo1g 1.3 ± 0.2 Yes Yes  
Q9D0S9 Hint2 1.3 ± 0.3 Yes Yes  
Q62261 Sptbn1 1.3 ± 0.2  Yes  
Q8BVI4 Qdpr 1.3 ± 0.2 Yes Yes  
O70443 Gnaz 1.3 ± 0.2 Yes Yes  
P18760 Cfl1 1.3 ± 0.3 Yes Yes  
Q62315 Jarid2 1.3 ± 0.2    
Q03963 Eif2ak2 1.3 ± 0.2    
P35802 Gpm6a 1.3 ± 0.4  Yes  
Q9D6R2 Idh3a 1.3 ± 0.2 Yes Yes 1 
O08749 Dld 1.3 ± 0.4 Yes Yes  
P38647 Hspa9 1.3 ± 0.4 Yes Yes 1 
O88737 Bsn 1.3 ± 0.3  Yes  
P70268 Pkn1 1.3 ± 0.3    
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Accession Symbol Exprs Mito synDB MCAO 
Q61879 Myh10 1.3 ± 0.3  Yes  
P62814 Atp6v1b2 1.3 ± 0.2  Yes  
P07901 Hsp90aa1 1.3 ± 0.3 Yes Yes  
P63328 Ppp3ca 1.3 ± 0.3 Yes Yes  
P56382 Atp5e 1.2 ± 0.2 Yes Yes  
P99028 Uqcrh 1.2 ± 0 Yes Yes  
P05201 Got1 1.2 ± 0.2 Yes Yes  
P16277 Blk 1.2 ± 0.3  Yes  
Q9CQA3 Sdhb 1.2 ± 0.3 Yes Yes  
P07146 Prss2 1.2 ± 0.2    
Q9WV55 Vapa 1.2 ± 0.3  Yes  
P28663 Napb 1.2 ± 0.2  Yes  
O35658 C1qbp 1.1 ± 0.2 Yes Yes  
Q9CZW5 Tomm70a 1.1 ± 0.2 Yes Yes  
Q9Z0J4 Nos1 1.1 ± 0.3 Yes Yes 66 
Q80XN0 Bdh1 1.1 ± 0.2 Yes Yes  
P34884 Mif 1.1 ± 0.2  Yes 3 
Q8K314 Atp2b1 1.1 ± 0.3  Yes  
Q640R3 Hepacam 1.1 ± 0.1  Yes  
Q5SWU9 Acaca 1.1 ± 0.1 Yes Yes  
Q00690 Sele 1.1 ± 0   26 
A2AJ76 Hmcn2 1 ± 0.3    
Q9JI46 Nudt3 1 ± 0.2  Yes  
Q6PCP5 Mff 1 ± 0.1 Yes Yes  
O70283 Wnt2b 1 ± 0.2    
P70295 Aup1 1 ± 0.2    
Q80Y86 Mapk15 1 ± 0.2  Yes  
Q9CQ54 Ndufc2 1 ± 0.2 Yes Yes  
P00405 Mtco2 1 ± 0.3 Yes Yes  
P63082 Atp6v0c 1 ± 0.2    
Q9D8W7 Ociad2 1 ± 0.2 Yes   
XP_922613 Spnb5 1 ± 0.3    
P43006 Slc1a2 1 ± 0.2  Yes 10 
Q9R111 Gda 1 ± 0.2  Yes  
Q9CQI3 Gmfb 0.9 ± 0.3  Yes  
XP_922643  0.9 ± 0.1    
O35857 Timm44 0.9 ± 0.2 Yes   
Q8BM92 Cdh7 0.9 ± 0.1  Yes  
P56564 Slc1a3 0.8 ± 0.2 Yes Yes  
O54983 Crym 0.9 ± 0.1 Yes   
NP_082646 Pot1b 0.9 ± 0.2    
Q9JKR6 Hyou1 0.9 ± 0.2    
Q9CQH3 Ndufb5 0.9 ± 0.2 Yes   
P48320 Gad2 0.9 ± 0.1  Yes 1 
Q61735 Cd47 0.9 ± 0.1   1 
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Accession Symbol Exprs Mito synDB MCAO 
Q9H4G0 EPB41L1 0.9 ± 0.2  Yes  
P08228 Sod1 0.9 ± 0.2 Yes Yes 10 
P62137 Ppp1ca 0.9 ± 0.3  Yes  
Q62277 Syp 0.9 ± 0.2  Yes 30 
Q9QZ83 Actg1 0.9 ± 0.2 Yes Yes  
A8E4K7 Pcdhb8 0.8 ± 0.1    
Q8K183 Pdxk 0.8 ± 0.2   2 
P08556 Nras 0.8 ± 0.2 Yes Yes  
Q61194 Pik3c2a 0.8 ± 0.3    
Q9DCS9 Ndufb10 0.8 ± 0.1 Yes Yes  
Q62420 Sh3gl2 0.8 ± 0.2  Yes  
P48771 Cox7a2 0.8 ± 0.3 Yes   
O35728 Cyp4a14 0.8 ± 0.1    
Q6GQS1 Slc25a23 0.8 ± 0.3 Yes   
Q9CWZ7 Napg 0.7 ± 0.1 Yes Yes  
Q99JY0 Hadhb 0.7 ± 0.1 Yes Yes  
Q8K0T0 Rtn1 0.7 ± 0.2  Yes  
P0CG49 Ubb 0.7 ± 0 Yes Yes 17 
P84091 Ap2m1 0.7 ± 0.1 Yes Yes  
P70335 Rock1 0.7 ± 0.2    
O09112 Dusp8 0.7 ± 0.1    
Q3UK37  0.7 ± 0.1    
Q8BLF1 Nceh1 0.7 ± 0.2    
Q76MZ3 Ppp2r1a 0.6 ± 0 Yes Yes  
Q8BGZ1 Hpcal4 0.6 ± 0.2  Yes  
B9EJA4 Clasp2 0.6 ± 0.1    
P05202 Got2 0.3 ± 1.6 Yes Yes 1 
Table 1. List of up-regulated proteins in the IS dataset. The expression (Exprs) of each 
proteins is provided (mean ± SD, n = 3), as well as their presence in the mitochondria (Mito) 
or synapse (SynDB). The number of citations in PubMed that have associated each proteins 
with stoke (MCAO) are also provided. 
To further characterize the IS dataset, the proteins were categorized into biological processes 
and subcellular localizations using a combination of Panther, Uniprot and other datasets 
(Taylor et al. 2003). Categorization by biological processes showed that the majority of the IS 
proteins are involved in transport, signal transduction, intracellular trafficking and 
carbohydrate metabolism (Fig. 7A). Additionally, up-regulated proteins were involved in 
the processes of immunity/defense, cell adhesion and neurogenesis. Subcellular 
classification mainly categorized the proteins into mitochondrial, cell membrane, 
cytoplasmic and membrane/cytoplasmic localizations (Fig. 7B). Consistent with our 
previous report (Costain et al. 2010), approximately half (51%) of the IS dataset were 
mitochondrial proteins (Fig. 7B), whereas < 25% of known synaptosomal proteins are 
mitochondrial. These changes were mainly due to mitochondrial oxidoreductases involved 
in electron transport and proteins involved in the TCA cycle, suggesting severe deficits in 
the capacity of the mitochondria to produce energy. About 20% of the identified ischemic  
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Accession Symbol Exprs Mito SynDB MCAO 
Q920I9 Wdr7 -3.3 ± 0.2  Yes  
Q8R1B4 Eif3c -3.3 ± 1.3  Yes  
P42356 PI4KA -2.9 ± 0.6  Yes  
Q8R071 Itpka -2.7 ± 0.5  Yes  
P67778 Phb -2.3 ± 0.4 Yes   
P19783 Cox4i1 -2.3 ± 0.8  Yes  
Q4U256 Ank3 -2.2 ± 0.6  Yes  
Q9DBG3 Ap2b1 -2.2 ± 0.5 Yes Yes  
P51881 Slc25a5 -2.1 ± 0.5 Yes   
Q3V1U8 Elmod1 -2.1 ± 0.5 Yes Yes  
P58281 Opa1 -2.1 ± 0.3  Yes  
Q64516 Gyk -2.1 ± 0.4  Yes  
Q99LY9 Ndufs5 -2 ± 0.6    
P54285 Cacnb3 -2 ± 0.7 Yes Yes  
Q8VD37 Sgip1 -2 ± 0.5  Yes  
P49615 Cdk5 -2 ± 0.4 Yes Yes  
Q62159 Rhoc -2 ± 0.6 Yes Yes 2 
Q9DB77 Uqcrc2 -2 ± 0.6  Yes  
Q9DCT2 Ndufs3 -2 ± 0.3 Yes Yes  
P21803 Fgfr2 -1.9 ± 0  Yes  
Q7TQD2 Tppp -1.9 ± 0.5 Yes Yes  
Q64521 Gpd2 -1.9 ± 0.6 Yes Yes  
P08249 Mdh2 -1.9 ± 0.2  Yes  
Q91WS0 Cisd1 -1.9 ± 0.7  Yes  
Q5DU25 Iqsec2 -1.9 ± 0.4    
Q03265 Atp5a1 -1.9 ± 0.2 Yes Yes  
Q9CPQ1 Cox6c -1.8 ± 0.5 Yes   
Q04447 Ckb -1.8 ± 0.3 Yes Yes  
P61161 Actr2 -1.8 ± 0.2 Yes Yes  
Q9D6J6 Ndufv2 -1.8 ± 0.5 Yes   
Q5NVN0 PKM2 -1.8 ± 0.4    
Q6PIC6 Atp1a3 -1.7 ± 0.4    
Q8QZT1 Acat1 -1.7 ± 0.6    
O08539 Bin1 -1.7 ± 0.7    
Q9JHU4 Dync1h1 -1.7 ± 0.3 Yes Yes  
Q91VR2 Atp5c1 -1.7 ± 0.4 Yes Yes  
P14618 PKM2 -1.7 ± 0.5  Yes  
O88935 Syn1 -1.6 ± 0.4    
Q9D0K2 Oxct1 -1.6 ± 0.5 Yes Yes  
Q61330 Cntn2 -1.6 ± 0.7 Yes Yes  
Q91XV3 Basp1 -1.6 ± 0.5  Yes  
Q3V1L4 Nt5c2 -1.6 ± 0.3 Yes Yes  
Q8BG39 Sv2b -1.6 ± 0.4    
P61982 Ywhag -1.6 ± 0.3 Yes Yes  
Q80ZF8 Bai3 -1.6 ± 0.4  Yes  
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Accession Symbol Exprs Mito SynDB MCAO 
P17427 Ap2a2 -1.6 ± 0.3 Yes Yes  
Q9DBF1 Aldh7a1 -1.6 ± 0.4 Yes Yes 8 
P39053 Dnm1 -1.5 ± 0.2 Yes Yes  
P70404 Idh3g -1.5 ± 0.1 Yes Yes  
P99024 Tubb5 -1.5 ± 0.3 Yes Yes  
P12787 Cox5a -1.5 ± 0.3 Yes Yes  
Q8CI94 Pygb -1.5 ± 0.6  Yes  
XP_001006010  -1.5 ± 0.1 Yes Yes  
Q9QXV0 Pcsk1n -1.5 ± 0.3  Yes  
P68368 Tuba4a -1.5 ± 0.3  Yes  
Q2EMV9 Parp14 -1.5 ± 0.3 Yes Yes 1 
P05064 Aldoa -1.5 ± 0.3  Yes  
NP_031573 Sirpa -1.4 ± 0.4  Yes  
O88342 Wdr1 -1.4 ± 0.4 Yes Yes  
Q9D0M3 Cyc1 -1.4 ± 0.2  Yes  
Q9QWI6 Srcin1 -1.4 ± 0.5    
Q69ZK9 Nlgn2 -1.4 ± 0.2  Yes  
P56480 Atp5b -1.4 ± 0.2  Yes  
Q8CIV2 ORF61 -1.4 ± 0.3 Yes Yes  
Q3UM45 Ppp1r7 -1.4 ± 0.5 Yes Yes  
O55100 Syngr1 -1.4 ± 0.2 Yes Yes  
P97797 Sirpa -1.3 ± 0.3 Yes Yes  
P51174 Acadl -1.3 ± 0.3    
Q9CZ13 Uqcrc1 -1.3 ± 0.4    
BAE40217 Tubb5 -1.3 ± 0.3  Yes 5 
AAA40509 Tubb4 -1.3 ± 0.4  Yes  
Q9WUM5 Suclg1 -1.3 ± 0.3    
Q8CHC4 Synj1 -1.3 ± 0.4 Yes Yes  
P14152 Mdh1 -1.3 ± 0.2 Yes Yes  
P17710 Hk1 -1.2 ± 0.2    
P23116 Eif3a -1.2 ± 0.1  Yes  
O43837 IDH3B -1.2 ± 0.4 Yes Yes  
Q9CZU6 Cs -1.2 ± 0.3  Yes  
XP_889898  -1.1 ± 0.3 Yes Yes  
Q6NXI6 Rprd2 -1.1 ± 0.2 Yes Yes  
NP_001013813 Gm5468 -1.1 ± 0.1 Yes Yes  
P11627 L1cam -1.1 ± 0.3 Yes Yes  
O77784 IDH3B -1.1 ± 0.4 Yes Yes  
Q9CPU4 Mgst3 -1.1 ± 0.1 Yes Yes  
Q8R570 Snap47 -1.1 ± 0.3  Yes  
Q8TCB6 OR51E1 -1.1 ± 0.2  Yes  
NP_082221 Csl -1.1 ± 0.4 Yes Yes  
Q9WUM4 Coro1c -1.1 ± 0.1 Yes Yes  
P10649 Gstm1 -1.1 ± 0.2  Yes  
Q9DB20 Atp5o -1 ± 0.2 Yes   
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Accession Symbol Exprs Mito SynDB MCAO 
Q9R0N5 Syt5 -1 ± 0.3 Yes Yes  
Q9QXY2 Srcin1 -1 ± 0.2  Yes  
Q9CQY6 LOC675054 -1 ± 0.2 Yes Yes  
Q3TC72 Fahd2 -1 ± 0.4 Yes Yes  
Q8BK30 Ndufv3 -1 ± 0.2  Yes 1 
Q9EQ20 Aldh6a1 -1 ± 0.3  Yes  
P30275 Ckmt1 -1 ± 0.2 Yes Yes 1 
Q8CHU3 Epn2 -1 ± 0.3 Yes Yes  
O35643 Ap1b1 -0.9 ± 0.2 Yes Yes  
O35874 Slc1a4 -0.9 ± 0.2  Yes  
P56391 Cox6b1 -0.9 ± 0.1 Yes Yes  
A2AGT5 Ckap5 -0.9 ± 0.2 Yes Yes  
P19536 Cox5b -0.9 ± 0.1  Yes  
Q60597 Ogdh -0.9 ± 0.3  Yes  
Q3TMW1 Ccdc102a -0.9 ± 0.2  Yes 4 
NP_570954 IDH3B -0.9 ± 0.4  Yes  
P61205 Arf3 -0.9 ± 0.2 Yes Yes  
Q9DC70 Ndufs7 -0.9 ± 0.3 Yes Yes  
Q61124 Cln3 -0.8 ± 0.2 Yes Yes  
Q99LC5 Etfa -0.8 ± 0.1    
P63040 Cplx1 -0.8 ± 0.1 Yes Yes  
Q8BH44 Coro2b -0.7 ± 0.1 Yes Yes 6 
Q9CXZ1 Ndufs4 -0.7 ± 0.1  Yes  
P49025 Cit -0.7 ± 0.1 Yes Yes  
Q7TQF7 Amph -0.7 ± 0.2 Yes Yes  
P48678 Lmna -0.7 ± 0.1 Yes Yes  
O89053 Coro1a -0.6 ± 0.1  Yes  
Q8BUV3 Gphn -0.6 ± 0.1  Yes  
P35831 Ptpn12 -0.6 ± 0.1    
Table 2. List of down-regulated proteins in the IS dataset. The expression (Exprs) of each 
proteins is provided (mean ± SD, n = 3), as well as their presence in the mitochondria (Mito) 
or synapse (SynDB). The number of citations in PubMed that have associated each proteins 
with stoke (MCAO) are also provided. 
proteins were classified as membrane/cytoplasmic, i.e., they exist in both cell membranes 
and cytoplasm. These 73 proteins consist of membrane trafficking proteins, transfer/carrier 
proteins, calcium-binding proteins, cytoskeletal proteins and transporters and are known to 
be involved in the processes of vesicle trafficking and synaptic transmission. Of the 
remaining identified ischemic proteins, 11% were classified as membrane-only and 9% as 
cytoplasm-only (Fig. 7B). The membrane-only proteins consist of transporters, adhesion 
molecules and cytokine receptors, which are known to be involved in the processes of cell 
adhesion, cell communication, signal transduction, neurogenesis and transport. The 
cytoplasm-only proteins consist of cytoskeletal proteins, enzymes (e.g., hydrolases, kinases, 
phosphatases) and G-proteins and are involved in the processes of signal transduction, cell 
structure maintenance and cell motility. 
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Fig. 7. Classification of differentially expressed proteins after targeted identification using 
nanoLC-MS/MS. (A) Protein classification by biological processes using the Panther 
classification system. (B) Protein classification by subcellular localizations using Panther, 
Uniprot and a dataset from Taylor et al. (2003). 
3.2 Statistical analysis of Gene Ontology meta data 
Graphical and statistical analyses of the Gene Ontology (GO) annotations were performed 
using the BiNGO 2.4.4 plugin for Cytoscape 2.8.2. This analysis involves gathering the GO 
meta data associated with the IS proteins, and determining if any annotations are 
statistically over-represented for each annotation category. BiNGO makes use of the 
hierarchical structure of the GO database to produce a graphical representation of the 
significantly over-represented ontologies, enabling the depiction of the parent-child 
relationships of the annotations. Fig. 8 is the graphical representation of the relative 
positions of the terms in the GO hierarchy, with the degree of significance indicated 
according to color (white nodes are not significant). The size of each node (area) is 
proportional to the number of proteins annotated to each node. The major, significant 
cellular component ontologies (Fig. 8A) are cytoplasm, mitochondrion, cytoskeleton, 
plasma membrane, cytoplasmic membrane-bounded vesicle, Golgi apparatus, 
endoplasmic reticulum and vacuole. This list indicates that cerebral ischemia induces 
dramatic alterations in the proteomes of organelles that are involved in regulating cell 
death/survival processes. This is further supported by the molecular function ontologies 
(Fig. 8C) that are significantly enriched in terms such as kinase activity, transporter 
activity, antioxidant activity, electron carrier activity and nucleotide binding. 
Additionally, the enriched biological process ontologies (Fig. 8B) are dominated by a 
variety of metabolic processes, as well as transport, cellular component organization, 
A B 
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cellular homeostasis, response to stress and response to external stimulus. Taken together, 
the gene ontology information paints a picture of a dynamic proteome that is responding 
to highly stressful injury. 
 
 
Fig. 8. Statistical analysis of Gene Ontology meta data. Statistical analysis of the Gene 
Ontology classification of the IS dataset was performed using the BiNGO plugin in 
Cytoscape. Graphical representations of significantly enriched ontologies are presented for 
cellular component (A), biological process (B) and molecular function (C). 
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Fig. 9. Identification of therapeutic targets using a network of interactions between the IS 
dataset and key proteins involved in cell death mechanisms. Networks were constructed 
with MiMI from regulators of cell death pathways for apoptosis (Map3k14, Endog, Aifm1, 
Apaf1, Cycs, Capn1, Casp8, Casp10), autophagy (Aup1, Map1lc3a, Atg3, Atg5, Atg7, 
Atg10, Atg12), necroptosis (Aifm1, Aifm2, Parp1, Ripk1) and ER stress (ERAD; Ern1, Ern2, 
Hspa5, Atf6, Eif2ak3). These networks were joined with an ischemia network constructed 
of interacting proteins in the IS dataset (diamonds). The expression of the ischemic 
synaptic proteins is mapped onto the nodes according to the scale provided, with  
red and green representing up- and down-regulation, respectively. Key proteins  
(highlighted with bold node borders) for joining the cell death networks to the  
ischemia network (Hsp90aa1, Tuba4a, Vim) as well as highly integrated proteins 
(Ywhag and Taf1) were identified. 
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3.3 Comparison with ischemic-responsive proteins identified by ICAT 
We recently identified 41 ischemia-responsive synaptosomal proteins at 20 h using ICAT-
based nanoLC-MS/MS proteomics. While the ICAT-based method exhibited a high 
quantitative reproducibility, quantitative accuracy, and a wide dynamic range (Costain et al. 
2010), it did not provide a very comprehensive analysis of the proteins. A comparison 
between the label-free and ICAT methods is shown in Table 3. While both methods have 
high quantitative reproducibility, the label-free method identified about 5-times more 
proteins and peptides in a synaptosome prep than the ICAT method. In addition, the 
number of peptides per protein and proteome coverage was significantly higher using the 
label-free method. The label-free method also showed higher peptide scores and identified 
several cysteine-free proteins. The label-free method identified 32 of the proteins that were 
also identified by ICAT (Fig. 6A) and the majority (80%) of their expressions values (i.e., fold 
change in response to MCAO) were in agreement between the two methods. Thus, while 
both methods are quantitatively comparable, the label-free approach provided a much more 
comprehensive coverage of the proteome and addressed some of the limitations of ICAT, 
including the detection of cysteine-free proteins. 
 
 
Fig. 10. Cerebral ischemia disrupts synaptosomal oxidative phosphorylation. An interaction 
network was constructed from proteins involved in oxidative phosphorylation using MiMI. 
The network segregated into proteins from 3 groups: complex I (NADH dehydrogenase 
(ubiquinone), complex IV (cytochrome-C oxidase) and complex V (ATP synthesis). 
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 Label-free ICAT t-test 
Mean number of ions detected by 
nanoLC-MS per sample 
>12,000 <4,000 p<0.0001 
Quantitative reproducibility (mean coefficient of variance) 10% 9% ns 
Total unique proteins identified 371 41  
Peptides per protein 3.9 1.2 p<0.0001 
Protein coverage (%) 15% 4.4% p<0.0001 
Peptide scores 71 32 p<0.0001 
Number of cysteine-free proteins 13 N/A  
Table 3. Statistical comparison of label-free and ICAT based nanoLC-MS proteomics. 
3.4 Protein interaction analysis 
In an effort to identify proteins that are important in mediating ischemia-induced cell death, 
interaction networks were constructed using the MiMI plugin in Cytoscape. Key proteins 
involved in initiating the four major active cell death mechanisms were identified and 
stringent interaction networks were individually constructed. Additionally, a network of 
interactions among the proteins in the IS dataset was constructed, which resulted in the 
generation of a network consisting of 203 proteins (IS network). The cell death networks 
were merged with the IS network, resulting in the identification of a number of proteins that 
are likely to be important mediators of synaptic pathology and cell death (Fig. 9). This 
analysis revealed a strong degree of association between apoptosis and necroptosis, but little 
direct interaction with autophagy. In comparison, ER associated degradation (ERAD) was 
associated with both necroptosis and autophagy. Fig. 9 indicates that the IS network is 
connected to apoptosis primarily through the vimentin (Vim) protein, whereas the 
necroptosis and ERAD networks are connected to the IS network in large part due to 
Hsp90aa1. In comparison, the autophagy network was connected to the IS network through 
Tuba4a. Additionally, the 14-3-3 protein Ywhag was revealed to be a highly connected 
protein within the IS network and the transcription factor Taf1 is a point of convergence for 
the ERAD, autophagy and necroptosis pathways. 
As mentioned, many of the IS proteins are involved in a group of activities that are of 
obvious importance to cellular metabolism and signaling. These functionalities are highly 
important in maintaining cellular homeostasis as well as in deciding cellular fate during 
injurious conditions. Fig. 10 is a graphical representation of the interactions among the 
proteins involved in the process of oxidative phosphorylation. The proteins segregated into 
three groups with related functions: cytochrome-C oxidase activity, NADH dehydrogenase 
(ubiquinone) activity and hydrogen ion transmembrane transporter activity. The expression 
of the proteins reveals that the Cox proteins were universally down-regulated, whereas 
proteins in the other groups exhibited more varied effects. Fig. 11A is a network of the 
proteins involved in glycolysis – gluconeogenesis. The figure demonstrates that there is 
widespread up-regulation of glycolytic proteins, with down-regulation of only two proteins. 
Similarly, Fig. 11B indicates that there is widespread up-regulation of proteins with anti-
oxidant activity. Interestingly, two of the proteins identified in Fig. 9, Hsp90aa1 and Taf1, 
are also involved in the antioxidant response. The results depicted in Fig. 11 clearly 
demonstrate that the ischemic synaptosomal proteome is actively engaged in an attempt to 
counteract the effects of cerebral ischemia, namely energy depletion and oxidative damage. 
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Fig. 11. Interaction network analysis demonstrates cellular responses to energy depletion 
and oxidative stress. Panel A is a network of proteins involved in glycolysis - 
gluconeogenesis, showing the up-regulation of proteins involved in this process. Panel B is a 
network showing the up-regulation of proteins with anti-oxidative properties. 
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Fig. 12. Interaction network of ischemia regulated protein kinases. The network shows the 
regulated kinases (diamonds) interact with a subset of 16 other proteins in the IS dataset. 
Actively regulated cell death processes rely on a variety of cellular signaling cascades, 
typically involving specific protein kinases. We found that the expression of 24 protein 
kinases were altered in post-ischemic synaptosomes and constructed an interaction network 
from this subset of proteins (Fig. 12). The resultant kinase network included 17 of the 24 
kinases as well as 16 non-kinase synaptosomal proteins that were in the IS dataset. 
Interestingly, three of the key proteins identified in Fig. 9 were present in the kinase 
network (Hsp90aa1, Vim and Taf1), supporting a broad role for these proteins in ischemic 
pathology. Interestingly, a group of proteins constituting the pyruvate dehydroxylase 
complex (Pdhb, Pdha1, Pdhx, Dld and Dlat), which links glycolysis and the tricarboxylic 
acid (TCA) cycle, were up-regulated, while citrate synthase (Cs) was down-regulated. The 
figure confirms that a wide variety of signaling pathways are affected by cerebral ischemia. 
4. Discussion 
The aim of this study is to characterize the effects of cerebral ischemia on the synaptic 
proteome and to examine the functional consequences of these alterations with particular 
emphasis on their relevance to neuronal cell death processes. As outlined, cellular protein 
levels are determined by the balance between synthesis and degradation, which is affected 
by a multitude of factors including: transcription, translation, proteases activity, and post-
translational modifications. Ischemic conditions complicate the matter by causing 
dysfunction in the proteosome (DeGracia et al. 2002) and endoplasmic reticulum (Ge et al. 
2007). Thus, gene expression data alone is a poor indicator of post-ischemic cellular protein 
levels. Furthermore focusing on the synapse adds the prospect of intracellular transport 
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mechanisms and localized translation further blurring the association between transcription 
and synaptic protein levels (Zhao et al. 2005, Vanderklish & Bahr 2000, Havik et al. 2003). As 
a result of these factors, the best approach for determining post-ischemic synaptic protein 
levels is to perform a direct assessment using proteomic methodologies. 
4.1 Cerebral ischemia-induced alterations in the synaptic proteome 
Here, we determined the proteomic response of the mouse brain synapse to cerebral 
ischemia by performing an analysis of mouse brain synaptosomes. Using a label-free 
nanoLC-MS/MS method, we identified 371 synaptosomal proteins that were altered 20 hrs 
after cerebral ischemia (Table 3), representing ≈ 27% of the total peaks detected. Linear 
regression analysis was used to exclude the possible influence of systemic bias on 
expression due to protein size and MASCOT score (Fig. 5). The purity of the synaptosomal 
prep was validated by the determination that > 80% of the IS dataset were previously 
characterized as being localized in the synapse (Fig. 6). Consistent with our previous study, 
the majority of the IS proteins were localized in the mitochondria (Costain et al. 2010), and 
the localization of the remaining proteins was consistent with the synaptic compartment. 
Furthermore, literature mining of PubMed indicated that only ≈ 15% of the IS proteins were 
associated with the MCAO model of cerebral ischemia. A statistical analysis of the 
ontological classification of the IS dataset revealed a number of important details (Fig. 8). 
Firstly, the significant enrichment of proteins located in the mitochondria, endoplasmic 
reticulum and Golgi apparatus indicate the importance of these structures in mediating 
post-ischemic neuronal function. Secondly, significantly enriched molecular function 
ontologies include kinase, transport, antioxidant and electron carrier activity. These 
functions are related to metabolism, and are consistent with tissues responding to 
catastrophic energy depletion. Lastly, the significantly enriched biological process 
ontologies were also associated with metabolism and stress responses. The present results, 
obtained using label-free nanoLC-MS/MS, are largely in agreement with our previous 
ICAT-based proteomics study (Table 3). The consistency between these datasets reflects the 
reproducibility and purity of synaptosomal preparations, as well as the proteomic 
methodologies. Furthermore, the label-free method produced a more comprehensive dataset 
than the ICAT method, exhibiting greater protein coverage, peptide scores and the ability to 
identify cysteine-free proteins.  
4.2 Interaction network analysis 
In an effort to place the observed alterations in the IS dataset into biological context, a 
variety of protein interaction analyses were performed. Interaction networks can be 
constructed from a variety of data types, such as protein-protein, protein-DNA and genetic 
interactions. The value of examining such interactions is that the overall biochemical 
function of proteins or DNA is a product of the interactions in which they participate. Thus, 
analyzing functional interactions enables the construction of signaling pathways or 
interaction networks that are capable of modeling a system or interpreting systematic 
responses to a given perturbation. In the present study, we used our observed systematic 
alterations in synaptosomal protein expression, and protein-protein interaction analyses to 
aid in interpreting the net effect of ischemia on the biological system (synapses and 
neurons). Furthermore, we integrated our observations in IS synaptosomes with key 
proteins in cell death pathways that are highly predictive of cell fate. Lastly, we focused on 
certain subsets of proteins to produce interaction networks that provided insight into the 
key biological processes. 
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BiNGO and MiMI are valuable analysis tools that are integrated into the Cytoscape 
framework. The GO networks created by BiNGO identify the statistically overrepresented 
ontologies associated with a given gene or protein dataset. This enables rapid identification 
and characterization of ontologies (biological process, molecular function, cellular location) 
that are specific to a given dataset, as well as the hierarchical nature of the ontologies. MiMI, 
on the other hand, gathers interaction information from various public databases and 
constructs an interaction network based on a list of proteins of interest. In these interaction 
networks, lines drawn between entities (proteins) can represent a variety of interactions, 
such as binding, phosphorylation, or other biologically relevant modifications. Such 
analyses allow for the identification of intermediary proteins that are important to the 
network, but are not directly identified by either biochemical analysis or literature mining. 
Importantly, interaction networks can be used to identify highly integrated ‘hubs’, which 
are likely to represent key factors in a given biological process or pathology.  
Cell death can occur either in an unregulated or a regulated manner. Apoptosis is a well-
studied regulated cell death mechanism, and awareness of regulated necrosis (necroptosis) 
has been increasing (Ankarcrona et al. 1995, Baines 2010, Hitomi et al. 2008). Additionally, 
autophagy and ER associated degradation (ERAD) are regulated processes that are vital to 
cell fate decisions during injurious conditions (Liu et al. 2010, Petrovski et al. 2011). 
Importantly, Liu et al. (2010) recently reported that cerebral ischemia induces protein 
aggregation, leading to multiple organelle damage that is likely to be responsible for 
delayed neuronal death. We constructed an IS protein interaction network that enabled the 
identification of five proteins that appear to be critical in linking the consequences of 
synaptic ischemia to regulated cell death processes (Fig. 9). Of the proteins identified, Vim 
appeared to provide the strongest association with apoptosis, whereas Hsp90aa1 was the 
protein that provided a link to necroptosis and ERAD. Although Vim is an intermediate 
filament protein expressed in glia that may not be expected to be found in the synapse, it is 
common to find proteins such as Vim and Gfap in synaptosomal preparations (Costain et al. 
2008) and is likely to be due to the intimate association between glia and synaptic structures. 
Nonetheless, up-regulation of Vim following cerebral ischemia has been frequently 
reported, and is thought to represent the activation of astrocytes and the reactive gliosis 
process. Furthermore, genetic ablation of Vim has been shown to counteract neuronal 
pathology, indicating that Vim is relevant to ischemic synaptosomal function (Pekny & 
Pekna 2004). Similarly, up-regulation of heat shock proteins, such as Hsp27 and Hsp70, in 
response to cerebral ischemia is a well-documented finding (Franklin et al. 2005, Currie & 
Plumier 1998). The Hsp90 family of molecular chaperones are involved in a variety of 
cellular processes, such as signal transduction, protein folding and protein degradation. 
Hsp90aa1 is the inducible cytoplasmic form of Hsp90 and aids in the folding of a wide 
variety of proteins. While other ischemia-responsive heat shock proteins that are associated 
with MCAO were identified in the present study (Table 1 and 2; Hspd1, Hspa9), Hsp90aa1 
has not previously been associated with cerebral ischemia and is therefore a good candidate 
for further examination of its role in ischemia-induced necroptosis and ERAD. 
The IS network analysis indicated that autophagy was associated with the IS dataset though 
the cytoskeletal protein Tuba4a (Fig. 9). Tuba4a has previously been identified as a synaptic 
protein, but has not been associated with MCAO. Alterations in cellular cytoskeletal 
proteins, such as Map2, are known to occur following exposure to ischemic injury 
(Kharlamov et al. 2009) and the observed reduction in Tuba4a expression is consistent with 
disruption of cytoskeletal structures. Reduced expression in other tubulin/tubulin related 
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proteins (Tubb4, Tubb5, Tppp) was also observed, indicating an autophagy-mediated failure 
in the microtubule system and collapse of the synaptic structure function relationship. 
Another interesting finding to arise from the IS network analysis is the prominence of the 
transcription factor Taf1 in connecting the autophagy, ERAD and necroptosis sub-networks. 
While Taf1 is involved in basal transcription, it has recently been found to be an important 
factor in certain neurodegenerative conditions (Davidson et al. 2009, Sako et al. 2011). 
Similarly, the down-regulated protein Ywhag was a highly integrated protein within the IS 
network, whereas the related protein Ywhaq was up-regulated with fewer interconnections 
(Fig. 9). There is growing interest in Ywhag as a mediator of neuroprotection in cerebral 
ischemia (Dong et al. 2010) and the observed decrease in its expression is consistent with the 
activation of cell death pathways. Additionally, up-regulation of Ywhaq has been observed 
in amyotrophic lateral sclerosis patients (Malaspina et al. 2000), and has been found to be 
necessary for autophagy (Wang et al. 2010). These findings suggest that the 14-3-3 proteins 
are likely to be playing an important role in mediating post-ischemic neuronal cell death 
and are good targets for therapeutic intervention in stroke.  
The role of mitochondria in the pathology of ischemic neuronal death (apoptotic and necrotic) 
is well established (Iijima 2006, Tsujimoto & Shimizu 2007). Cerebral ischemia results in a 
sustained increase in intracellular Ca++ that is buffered by the mitochondria. The increased 
Ca++ levels disrupt the mitochondrial membrane potential and induce the formation of the 
permeability transition pore, thereby activating the intrinsic apoptosis pathway (Tsujimoto & 
Shimizu 2007). In the synaptosome, hypoxia induces mitochondrial membrane potential 
disruption (Aldinucci et al. 2007) and Brown et al (2006) have demonstrated that synaptic 
mitochondria are more sensitive to Ca++ overload than non-synaptic mitochondria. Our 
present findings confirm our previous observation that widespread alterations in protein 
expression occur in post-ischemic synaptic mitochondria (Costain et al. 2010). An interaction 
network was constructed from the large number of IS proteins that are involved in oxidative 
phosphorylation (Fig. 10). This interaction network clearly demonstrates that cerebral ischemia 
induces an imbalance in oxidative phosphorylation, with down-regulation of complex IV 
components and more variable effects on complex I and V. While oxidative phosphorylation is 
clearly disrupted, there is evidence that the cells are attempting to compensate by up-
regulating glycolytic enzymes (Fig. 11A) as well as proteins with anti-oxidative activity (Fig. 
11B). Unfortunately, glycolysis cannot produce the same amount of ATP that is derived from 
oxidative phosphorylation. 
A wide variety of protein kinases are involved in mediating regulated cell death, and we 
identified a subset of 24 protein kinases within the IS dataset. An interaction network was 
constructed from the IS kinases subset (Fig. 12) and the kinase network independently 
identified three of the key proteins singled out in the IS network analysis (Fig. 9), 
supporting the contention that these proteins are involved in post-ischemic cell signaling 
pathways. Hsp90aa1, Taf1 and Vim were essential for connecting the four cell death 
mechanisms to the IS dataset, and their association with alterations in protein kinase levels 
further confirms their importance in mediating synaptic pathology. 
5. Conclusion 
In closing, this study has demonstrated that the synapse is highly responsive to cerebral 
ischemia and is highly informative about cerebral ischemia-induced cell death mechanisms 
at the organelle level. We have used interaction network analyses of the IS dataset to clarify 
www.intechopen.com
 Cerebral Ischemia Induced Proteomic Alterations: Consequences for the Synapse and Organelles 
 
113 
the effects cerebral ischemia on metabolic function, as well as to identify five proteins that 
are integral to cell death pathways and are potential targets for therapeutic intervention. 
This report also confirms that cerebral ischemia induces marked aberrations in synaptic 
mitochondria, lysosomes, endoplasmic reticulum and golgi apparatus, thereby emphasizing 
the interplay between organelles during oxidative damage. 
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